These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 35199282

  • 1. Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis.
    Olson AL, Hartmann N, Patnaik P, Garry EM, Bohn RL, Singer D, Baldwin M, Wallace L.
    Adv Ther; 2022 Apr; 39(4):1794-1809. PubMed ID: 35199282
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
    Olson AL, Patnaik P, Hartmann N, Bohn RL, Garry EM, Wallace L.
    Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606
    [Abstract] [Full Text] [Related]

  • 3. Burden of illness in progressive fibrosing interstitial lung disease.
    Singer D, Bengtson LGS, Conoscenti CS, Anderson AJ, Brekke L, Shetty SS, Brown KK.
    J Manag Care Spec Pharm; 2022 Aug; 28(8):871-880. PubMed ID: 35876293
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
    Singer D, Bengtson LGS, Conoscenti CS, Laouri M, Shetty SS, Anderson AJ, Brown KK.
    Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
    [Abstract] [Full Text] [Related]

  • 7. Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype.
    Nili M, Singer D, Hanna M.
    BMC Pulm Med; 2022 Apr 23; 22(1):153. PubMed ID: 35459138
    [Abstract] [Full Text] [Related]

  • 8. The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach.
    Wuyts WA, Papiris S, Manali E, Kilpeläinen M, Davidsen JR, Miedema J, Robalo-Cordeiro C, Morais A, Artés M, Asijee G, Cendoya D, Soulard S.
    Adv Ther; 2020 Jul 23; 37(7):3246-3264. PubMed ID: 32445186
    [Abstract] [Full Text] [Related]

  • 9. Burden of illness in patients with pulmonary hypertension due to interstitial lung disease: a real-world analysis.
    Heresi G, Dean B, Wu B, Lee H, Sketch MR, Stafkey-Mailey D, Morland K, Classi P, Spikes L.
    BMC Pulm Med; 2024 Jul 11; 24(1):335. PubMed ID: 38992626
    [Abstract] [Full Text] [Related]

  • 10. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M, Larrieu S, Boussel L, Si-Mohamed S, Bazin F, Marque S, Massol J, Thivolet-Bejui F, Chalabreysse L, Maucort-Boulch D, Hachulla E, Jouneau S, Le Lay K, Cottin V.
    Respir Res; 2021 May 24; 22(1):162. PubMed ID: 34030695
    [Abstract] [Full Text] [Related]

  • 11. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.
    Wijsenbeek M, Kreuter M, Olson A, Fischer A, Bendstrup E, Wells CD, Denton CP, Mounir B, Zouad-Lejour L, Quaresma M, Cottin V.
    Curr Med Res Opin; 2019 Nov 24; 35(11):2015-2024. PubMed ID: 31328965
    [Abstract] [Full Text] [Related]

  • 12. Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study.
    Joung KI, Park H, Park S, Shin JY, Kim YH.
    BMC Pulm Med; 2023 Mar 22; 23(1):98. PubMed ID: 36949407
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.
    Yu YF, Wu N, Chuang CC, Wang R, Pan X, Benjamin NN, Devercelli G, Coultas DB.
    J Manag Care Spec Pharm; 2016 Apr 22; 22(4):414-23. PubMed ID: 27023695
    [Abstract] [Full Text] [Related]

  • 16. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
    Faverio P, Piluso M, De Giacomi F, Della Zoppa M, Cassandro R, Harari S, Luppi F, Pesci A.
    Respiration; 2020 Apr 22; 99(10):838-845. PubMed ID: 33264777
    [Abstract] [Full Text] [Related]

  • 17. Impact of chronic fibrosing interstitial lung disease on healthcare use: association between fvc decline and inpatient hospitalization.
    Singer D, Chastek B, Sargent A, Johnson JC, Shetty S, Conoscenti C, Bernstein EJ.
    BMC Pulm Med; 2023 Sep 09; 23(1):337. PubMed ID: 37689630
    [Abstract] [Full Text] [Related]

  • 18. Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey.
    Olson A, Hartmann N, Patnaik P, Wallace L, Schlenker-Herceg R, Nasser M, Richeldi L, Hoffmann-Vold AM, Cottin V.
    Adv Ther; 2021 Feb 09; 38(2):854-867. PubMed ID: 33315170
    [Abstract] [Full Text] [Related]

  • 19. Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease.
    Schmid U, Weber B, Magnusson MO, Freiwald M.
    Respir Med; 2021 Feb 09; 180():106369. PubMed ID: 33798871
    [Abstract] [Full Text] [Related]

  • 20. Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study).
    Nasser M, Larrieu S, Si-Mohamed S, Ahmad K, Boussel L, Brevet M, Chalabreysse L, Fabre C, Marque S, Revel D, Thivolet-Bejui F, Traclet J, Zeghmar S, Maucort-Boulch D, Cottin V.
    Eur Respir J; 2021 Feb 09; 57(2):. PubMed ID: 32943410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.